Prospective Cohort Study of the Risk of Recurrent Atrial Fibrillation After Radiofrequency Ablation
Recruiting · NCT05638841 · Observational (researchers observe without assigning treatment) · Lead sponsor: Peking University Third Hospital
View the official record on ClinicalTrials.gov →Interventions studied
After radiofrequency ablation of atrial fibrillation
What this trial is about
In this study, the continuous inclusion of atrial fibrillation patients treated by catheter ablation in the Department of Cardiology, Peking University Third Hospital, through the collection of clinical data and outpatient follow-up, to explore the risk factors of atrial fibrillation recurrence after catheter ablation and the influencing factors of major clinical events in atrial fibrillation patients, and further guide the management mode of atrial fibrillation patients.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- 1\) Age \> 18
- 2\) ECG or holter electrocardiogram confirmed atrial fibrillation
Exclusion criteria
- 1\) Hematological diseases, autoimmune diseases and malignant tumors
- 2\) Immobility caused by hemiplegia or severe trauma
- 3\) The expected survival time is less than 2 years
- 4\) Poor compliance and high risk of expected loss of follow-up
- 5\) Disorders of consciousness or Alzheimer's disease
Where it is running
1 location listed.
- Peking-University-Third-Hospital - Beijing, China